Deriving a mutation index of carcinogenicity using protein structure and protein interfaces

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Espinosa, Octavio ^a   Mitsopoulos, Konstantinos ^a   Hakas, Jarle ^a   Pearl, Frances ^a,b   Zvelebil, Marketa ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN;

ARTICLE; CARCINOGENICITY; DISEASE COURSE; DNA SEQUENCE; GENE IDENTIFICATION; GENE MUTATION; HUMAN; LUNG ADENOCARCINOMA; MICROENVIRONMENT; MISSENSE MUTATION; PHENOTYPE; PREDICTION; PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; CARCINOGEN TESTING; CHEMISTRY; GENETICS; MUTATION; STATIC ELECTRICITY;

CARCINOGENICITY TESTS; HUMANS; MUTATION; PROTEINS; STATIC ELECTRICITY;

EID: 84898646417     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084598     Document Type: Article

References (67)

1. Croce CM (2008) Oncog (Pubitemid 351185806)
2. Stratton MR (2011) Exploring the genomes of cancer cells: progress and promise. Science 331:1553-1558.
3. Stratton MR, Campbell PJ, Futreal PA (2009) The cancer genome. Nature 458:719-724.
4. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, et al. (2004) A census of human cancer genes. Nat Rev Cancer 4:177-183. (Pubitemid 38337497)
5. Mardis ER, Wilson RK (2009) Cancer genome sequencing: a review. Hum Mol Genet 18:R163-168.
6. Hamosh A, Scott AF, Amberger JS, Bocchini CA, McKusick VA (2005) Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res 33:D514-517. (Pubitemid 40207927)
7. Stenson PD, Mort M, Ball EV, Howells K, Phillips AD, et al. (2009) The Human Gene Mutation Database: 2008 update. Genome Med 1:13.
8. David A, Razali R, Wass MN, Sternberg MJ (2012) Protein-protein interaction sites are hot spots for disease-associated nonsynonymous SNPs. Hum Mutat 33:359-363.
9. Hurst JM, McMillan LE, Porter CT, Allen J, Fakorede A, et al. (2009) The SAAPdb web resource: a large-scale structural analysis of mutant proteins. Hum Mutat 30:616-624.
10. Ng PC, Henikoff S (2006) Predicting the effects of amino acid substitutions on protein function. Annu Rev Genomics Hum Genet 7:61-80. (Pubitemid 44627922)
11. Ferla R, Calo V, Cascio S, Rinaldi G, Badalamenti G, et al. (2007) Founder mutations in BRCA1 and BRCA2 genes. Ann Oncol 18 Suppl 6: vi93-98.
12. Rajasekaran R, Sudandiradoss C, Doss CG, Sethumadhavan R (2007) Identification and in silico analysis of functional SNPs of the BRCA1 gene. Genomics 90:447-452. (Pubitemid 47404805)
13. Dixit A, Yi L, Gowthaman R, Torkamani A, Schork NJ, et al. (2009) Sequence and structure signatures of cancer mutation hotspots in protein kinases. PLoS One 4:e7485.
14. Talavera D, Taylor MS, Thornton JM (2010) The (non) malignancy of cancerous amino acidic substitutions. Proteins 78:518-529.
15. Kumar P, Henikoff S, Ng PC (2009) Predicting the effects of coding nonsynonymous variants on protein function using the SIFT algorithm. Nat Protoc 4:1073-1081.
16. Chan PA, Duraisamy S, Miller PJ, Newell JA, McBride C, et al. (2007) Interpreting missense variants: comparing computational methods in human disease genes CDKN2A, MLH1, MSH2, MECP2, and tyrosinase (TYR). Hum Mutat 28:683-693. (Pubitemid 47047295)
17. Ng PC, Henikoff S (2003) SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res 31:3812-3814. (Pubitemid 37442253)
18. Bromberg Y, Rost B (2007) SNAP: predict effect of non-synonymous polymorphisms on function. Nucleic Acids Res 35:3823-3835. (Pubitemid 47244674)
19. Frederic MY, Lalande M, Boileau C, Hamroun D, Claustres M, et al. (2009) UMD-predictor, a new prediction tool for nucleotide substitution pathogenicity - application to four genes: FBN1, FBN2, TGFBR1, and TGFBR2. Hum Mutat 30:952-959.
20. Greenblatt MS, Beaudet JG, Gump JR, Godin KS, Trombley L, et al. (2003) Detailed computational study of p53 and p16: using evolutionary sequence analysis and disease-associated mutations to predict the functional consequences of allelic variants. Oncogene 22:1150-1163. (Pubitemid 36363379)
21. Chao EC, Velasquez JL, Witherspoon MS, Rozek LS, Peel D, et al. (2008) Accurate classification of MLH1/MSH2 missense variants with multivariate analysis of protein polymorphisms-mismatch repair (MAPP-MMR). Hum Mutat 29:852-860. (Pubitemid 351794136)
22. Carter H, Chen S, Isik L, Tyekucheva S, Velculescu VE, et al. (2009) Cancerspecific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations. Cancer Res 69:6660-6667.
23. Chasman D, Adams RM (2001) Predicting the functional consequences of nonsynonymous single nucleotide polymorphisms: structure-based assessment of amino acid variation. J Mol Biol 307:683-706. (Pubitemid 33027685)
24. Ramensky V, Bork P, Sunyaev S (2002) Human non-synonymous SNPs: server and survey. Nucleic Acids Res 30:3894-3900. (Pubitemid 35012462)
25. Sunyaev S, Ramensky V, Koch I, Lathe W 3rd, Kondrashov AS, et al. (2001) Prediction of deleterious human alleles. Hum Mol Genet 10:591-597. (Pubitemid 32229363)
26. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, et al. (2010) A method and server for predicting damaging missense mutations. Nat Methods 7:248-249.
27. De Baets G, Van Durme J, Reumers J, Maurer-Stroh S, Vanhee P, et al. (2012) SNPeffect 4.0: on-line prediction of molecular and structural effects of proteincoding variants. Nucleic Acids Res 40:D935-939.
28. Lee PH, Shatkay H (2008) F-SNP: computationally predicted functional SNPs for disease association studies. Nucleic Acids Res 36:D820-824. (Pubitemid 351149829)
29. Reva B, Antipin Y, Sander C (2011) Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res 39:e118.
30. Wang K, Li M, Hakonarson H (2010) ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 38:e164.
31. Richardson CJ, Gao Q, Mitsopoulous C, Zvelebil M, Pearl LH, et al. (2009) MoKCa database-mutations of kinases in cancer. Nucleic Acids Res 37:D824-831.
32. Izarzugaza JM, Redfern OC, Orengo CA, Valencia A (2009) Cancer-associated mutations are preferentially distributed in protein kinase functional sites. Proteins 77:892-903.
33. Jones S, Thornton JM (1996) Principles of protein-protein interactions. Proc Natl Acad Sci U S A 93:13-20. (Pubitemid 26038096)
34. Moreira IS, Fernandes PA, Ramos MJ (2007) Hot spots-a review of the proteinprotein interface determinant amino-acid residues. Proteins 68:803-812. (Pubitemid 47434705)
35. Velankar S, Kleywegt GJ (2011) The Protein Data Bank in Europe (PDBe): bringing structure to biology. Acta Crystallogr D Biol Crystallogr 67:324-330.
36. Boutselakis H, Dimitropoulos D, Fillon J, Golovin A, Henrick K, et al. (2003) E-MSD: the European Bioinformatics Institute Macromolecular Structure Database. Nucleic Acids Res 31:458-462. (Pubitemid 36150430)
37. Krissinel E, Henrick K (2007) Inference of macromolecular assemblies from crystalline state. J Mol Biol 372:774-797. (Pubitemid 47321791)
38. Morris JR, Keep NH, Solomon E (2002) Identification of residues required for the interaction of BARD1 with BRCA1. J Biol Chem 277:9382-9386. (Pubitemid 34953023)
39. Wang X, Wei X, Thijssen B, Das J, Lipkin SM, et al. (2012) Three-dimensional reconstruction of protein networks provides insight into human genetic disease. Nat Biotechnol.
40. Carlsson J, Soussi T, Persson B (2009) Investigation and prediction of the severity of p53 mutants using parameters from structural calculations. FEBS J 276:4142-4155.
41. Pal A, Bahadur RP, Ray PS, Chakrabarti P (2009) Accessibility and partner number of protein residues, their relationship and a webserver, ContPlot for their display. BMC Bioinformatics 10:103.
42. Kabsch W, Sander C (1983) Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22:2577-2637.
43. Magrane M, Consortium U (2011) UniProt Knowledgebase: a hub of integrated protein data. Database (Oxford) 2011: bar009.
44. Hornbeck PV, Kornhauser JM, Tkachev S, Zhang B, Skrzypek E, et al. (2012) PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse. Nucleic Acids Res 40:D261-270.
45. The 1000 Genomes Project Consortium (2010) A map of human genome variation from population-scale sequencing. Nature 467:1061-1073.
46. Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, et al. (2011) COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res 39:D945-950.
47. Flicek P, Amode MR, Barrell D, Beal K, Brent S, et al. (2011) Ensembl 2011. Nucleic Acids Res 39:D800-806.
48. Kinsella RJ, Kahari A, Haider S, Zamora J, Proctor G, et al. (2011) Ensembl BioMarts: a hub for data retrieval across taxonomic space. Database (Oxford) 2011: bar030.
49. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, et al. (2013) Cancer genome landscapes. Science 339:1546-1558.
50. Chou PY, Fasman GD (1974) Prediction of protein conformation. Biochemistry 13:222-245.
51. MacArthur MW, Thornton JM (1991) Influence of proline residues on protein conformation. J Mol Biol 218:397-412. (Pubitemid 121003355)
52. Xu D, Tsai CJ, Nussinov R (1997) Hydrogen bonds and salt bridges across protein-protein interfaces. Protein Eng 10:999-1012. (Pubitemid 28004646)
53. Crowley PB, Golovin A (2005) Cation-pi interactions in protein-protein interfaces. Proteins 59:231-239.
54. Breiman L (2001) Random forests. Machine Learning 45:5-32. (Pubitemid 32933532)
55. Huang da W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57.
56. Sims D, Bursteinas B, Gao Q, Jain E, MacKay A, et al. (2010) ROCK: a breast cancer functional genomics resource. Breast Cancer Res Treat 124:567-572.
57. Wang X, Wang E, Kavanagh JJ, Freedman RS (2005) Ovarian cancer, the coagulation pathway, and inflammation. J Transl Med 3:25.
58. Custodio A, Lopez-Farre AJ, Zamorano-Leon JJ, Mateos-Caceres PJ, Macaya C, et al. (2012) Changes in the expression of plasma proteins associated with thrombosis in BRCA1 mutation carriers. J Cancer Res Clin Oncol 138:867-875.
59. Makishima H, Visconte V, Sakaguchi H, Jankowska AM, Abu Kar S, et al. (2012) Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis. Blood 119:3203-3210.
60. Damm F, Nguyen-Khac F, Fontenay M, Bernard OA (2012) Spliceosome and other novel mutations in chronic lymphocytic leukemia and myeloid malignancies. Leukemia 26:2027-2031.
61. Li M, Yu X (2013) Function of BRCA1 in the DNA Damage Response Is Mediated by ADP-Ribosylation. Cancer Cell 23:693-704.
62. Birrane G, Varma AK, Soni A, Ladias JA (2007) Crystal structure of the BARD1 BRCT domains. Biochemistry 46:7706-7712. (Pubitemid 47016055)
63. Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, et al. (2008) Somatic mutations affect key pathways in lung adenocarcinoma. Nature 455:1069-1075.
64. Anne TM, Taina TH (2010) Levels of Circulating TIMP-2 and MMP2-TIMP2 Complex Are Decreased in Squamous Cervical Carcinoma. Obstet Gynecol Int 2010:179351.
65. Srivastava P, Lone TA, Kapoor R, Mittal RD (2012) Association of promoter polymorphisms in MMP2 and TIMP2 with prostate cancer susceptibility in North India. Arch Med Res 43:117-124.
66. Bass AJ, Lawrence MS, Brace LE, Ramos AH, Drier Y, et al. (2011) Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion. Nat Genet 43:964-968.
67. Wan PT, Garnett MJ, Roe SM, Lee S, Niculescu-Duvaz D, et al. (2004) Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell 116:855-867. (Pubitemid 38410730)